A study to assess the action of belladonna and bryonia alba on inflammatory modulations produced in cases of rheumatoid arthritis through c reactive protein analysis

A randomized comparative interventional study to assess the efficacy of Belladonna and Bryonia alba on inflammatory modulations produced in the cases of Rheumatoid arthritis through variations in c reactive protein readings

Status

Active, not recruiting

Phases

Phase 3Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2022/06/043589

Enrollment

Registered

2022-06-30

Start date

Unknown

Completion date

Unknown

Last updated

2023-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M057- Rheumatoid arthritis with rheumatoid factor without organ or systems involvement

Interventions

Intervention1: Belladonna: Belladonna will be administered in either 30CH 200CH or 1M as per similarity of symptoms for atleast 6 upcoming follow ups Intervention2: Bryonia alba: Bryonia alba is pre

Eligibility

Inclusion criteria

Inclusion criteria: 1 Clinically diagnosed patients of rheumatoid arthritis Previously Diagnosed cases of Rheumatoid arthritis reoccurring, with other medicine with no avail. 2 Patient’s having CRP variations 3 Patients of age group below 65 years and both the sexes will be considered. 4 Patient giving consent and maintaining follow up

Exclusion criteria

Exclusion criteria: 1 Patients having extra articular manifestations 2 Patient are not giving consent and maintaining follow up

Design outcomes

Primary

Measure	Time frame
The primary outcome of my study is to assess the effect of belladonna and bryonia alba through pre and post reports of CRP .Timepoint: The primary outcome of my study is to assess the effect of belladonna and bryonia alba through pre and post reports of CRP at 3 months	—

Secondary

Measure	Time frame
The secondary outcome is to assess the effect of belladonna and bryonia alba in reduction of DAS28 score and changes in score of health assessment questionniare.Timepoint: 1 year	—

Countries

India

Contacts

Public ContactDr Mansi Mishra

Homoeopathy University

drashok112@gmail.com9829053664

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026